CLINICAL EFFECT OF VEDOLIZUMAB ON ARTICULAR MANIFESTATIONS IN PATIENTS WITH SPONDYLOARTHRITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE

被引：2
|
作者：
Paccou, J. [1 ]
Nachury, M. [1 ]
Duchemin, C. [1 ]
Desreumaux, P. [1 ]
Flipo, R. -M. [1 ]
Pariente, B. [1 ]
机构：
[1] Lille Univ Hosp, Lille, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.3068
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0029
引用
收藏
页码：64 / 65
页数：2
相关论文
共 50 条
  • [21] VEDOLIZUMAB INDUCES DE NOVO EXTRAINTESTINAL MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Kim, Su Bin
    Diaz, Liege I.
    Calmet, Fernando
    Quintero, Maria A.
    Schwartz, Ingrid
    Abreu, Maria T.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S360 - S360
  • [22] Effect of vedolizumab and ustekinumab on articular manifestations in patients with inflammatory bowel disease refractory or intolerant to anti-TNF therapy: An observational prospective study
    Britschu, O.
    Meyer, A.
    Gottenberg, J. E.
    Reimund, J. M.
    Caron, B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S472 - S473
  • [23] Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician
    Lubrano, Ennio
    Luchetti, Michele Maria
    Benfaremo, Devis
    Mauro, Daniele
    Ciccia, Francesco
    Perrotta, Fabio Massimo
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (11) : 1199 - 1209
  • [24] Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
    Mark Fleisher
    Jan Marsal
    Scott D. Lee
    Laura E. Frado
    Alyssa Parian
    Burton I. Korelitz
    Brian G. Feagan
    [J]. Digestive Diseases and Sciences, 2018, 63 : 825 - 833
  • [25] Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
    Fleisher, Mark
    Marsal, Jan
    Lee, Scott D.
    Frado, Laura E.
    Parian, Alyssa
    Korelitz, Burton I.
    Feagan, Brian G.
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (04) : 825 - 833
  • [26] Clinical and epidemiological features of patients with inflammatory bowel disease and extraintestinal manifestations associated
    Marin Pedrosa, S.
    Perez Medrano, I.
    Iglesias Flores, E.
    Benitez Cantero, J. M.
    Salgueiro Rodriguez, I.
    Garcia Garcia, M. L.
    Aguilar Melero, P.
    Gomez Camacho, F.
    Garcia Sanchez, V.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S340 - S340
  • [27] The onset of clinical manifestations in patients with inflammatory bowel disease
    Nobrega, V.
    Silva, J.
    Brito, B.
    Silva, I.
    Silva, M. C.
    Pimentel, A.
    Fortes, F.
    da Silva, B. C.
    Almeida, N.
    Almeida, N.
    Surlo, V.
    Mota, J.
    Santana, G.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S204 - S205
  • [28] ASSESSMENT OF CLINICAL SIGNS OF SPONDYLOARTHRITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Belousova, E.
    Abdulganieva, D.
    Protopopov, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1560 - 1560
  • [29] New Onset/Recurrence of Inflammatory Arthralgia/Spondyloarthritis in Patients Treated with Vedolizumab for Intestinal Bowel Disease
    Tamanini, Silvia
    Fredi, Micaela
    Bazzani, Chiara
    Lazzaroni, Maria Grazia
    Fernandes, Melissa
    Nalli, Cecilia
    Tincani, Angela
    Franceschini, Franco
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [30] Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease
    Dubinsky, Marla C.
    Cross, Raymond K.
    Sandborn, William J.
    Long, Millie
    Song, Xue
    Shi, Nianwen
    Ding, Yao
    Eichner, Samantha
    Pappalardo, Brandee
    Ganguli, Arijit
    Wang, Anthony
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 (09) : 1876 - 1882
12345